List view / Grid view




Leukaemia study takes aim at therapy resistant proteins

28 July 2016 | By Caleb Radford, The Lead

Assessing a patient's levels of the P-glycoprotein soon after they start receiving Glivec therapy will help to predict that patient’s long-term response to the leukaemia drug, according to new research from SAHMRI and the University of Adelaide...